Compounds > pteridines

pteridines and vorinostat

pteridines has been researched along with vorinostat in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Carducci, MA; Gonzalez, M; Hammers, H; Kachhap, SK; Kaelber, NS; Kim, E; Kortenhorst, MS; Mendonca, J; van Diest, PJ; Wissing, MD1
Gohda, J; Inoue, JI; Ishida, T; Kawaguchi, Y; Liu, K; Suzuki, K; Takeuchi, H; Xie, X1
Acikelli, AH; Andrioff, S; D'Souza, F; Dammann, P; Demmig, R; Díaz-Carballo, D; Erwes, J; Grandi, N; Homp, E; Klein, D; Klein, J; Malak, S; Menze, S; Nasreen, A; Noa-Bolaño, A; Ochsenfarth, C; Pano, E; Saka, S; Schröer, K; Strumberg, D; Tannapfel, A; Teipel, M; Tramontano, E1

Other Studies

3 other study(ies) available for pteridines and vorinostat

ArticleYear
Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013, Volume: 27, Issue:10

    Topics: Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Male; Polo-Like Kinase 1; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Valproic Acid; Vorinostat

2013
BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1.
    Scientific reports, 2018, 02-23, Volume: 8, Issue:1

    Topics: Cell Line, Tumor; Drug Combinations; Gene Expression Regulation, Viral; Histone Deacetylase Inhibitors; HIV-1; Host-Pathogen Interactions; Humans; Inhibitory Concentration 50; Leukocytes, Mononuclear; Lymphocytes; Monocytes; Phorbol Esters; Primary Cell Culture; Protein Domains; Protein Kinase Inhibitors; Pteridines; RNA, Messenger; RNA, Viral; THP-1 Cells; Transcription, Genetic; Virus Activation; Virus Latency; Vorinostat

2018
Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors.
    Communications biology, 2021, 03-03, Volume: 4, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Depsipeptides; Endogenous Retroviruses; Female; Histone Deacetylase Inhibitors; Humans; Imiquimod; Immunity, Innate; Mice, Nude; Ovarian Neoplasms; Pteridines; Signal Transduction; Toll-Like Receptor 7; Tumor Cells, Cultured; Viral Envelope Proteins; Virus Activation; Vorinostat; Xenograft Model Antitumor Assays

2021